Aadel Chaudhuri, MD PhD
About Aadel Chaudhuri, MD PhD
Aadel Chaudhuri, MD PhD, is a co-founder of Droplet Biosciences and serves as an Assistant Professor at Washington University School of Medicine in St. Louis, where he holds joint appointments in Genetics, Computer Science, and Biomedical Engineering.
Work at Droplet
Aadel Chaudhuri serves as a Co-Founder at Droplet Biosciences, Inc., a company dedicated to advancing liquid biopsy technologies. Droplet focuses on innovative approaches to cancer detection and treatment monitoring through the use of circulating tumor DNA (ctDNA). The company aims to improve patient outcomes by providing more accurate and less invasive diagnostic options.
Education and Expertise
Aadel Chaudhuri holds a Doctor of Medicine (M.D.) from Stanford University School of Medicine, where he studied the Molecular Basis of Medicine. He also earned a Doctor of Philosophy (Ph.D.) in Biology from Caltech. Additionally, he completed his undergraduate studies at the Massachusetts Institute of Technology, majoring in Biology and Electrical Engineering/Computer Science, with a minor in Biomedical Engineering. His educational background supports his expertise in genetics, computer science, and biomedical engineering.
Background
Aadel Chaudhuri has a diverse professional background in medicine and research. He has held various positions, including Assistant Professor in multiple departments at Washington University in St. Louis, where he has been since 2018. His previous roles include Chief Resident in Radiation Oncology at Stanford Health Care and Visiting Scientist at The Scripps Research Institute. His experience spans clinical practice, research, and advisory roles in several organizations.
Achievements
Aadel Chaudhuri is recognized as a V Foundation V Scholar for his contributions to cancer research. He leads the Liquid Biopsy Working Group at Siteman Cancer Center, focusing on the application of circulating tumor DNA (ctDNA) in cancer detection and treatment monitoring. His research efforts contribute to advancements in understanding minimal residual disease (MRD) detection, enhancing the field of oncology.
Current Roles and Affiliations
In addition to his role at Droplet Biosciences, Aadel Chaudhuri holds several advisory and consulting positions. He serves as an Advisor at Roche, a Healthcare Consultant at Guidepoint, and is part of the Scientific Advisory Board at Geneoscopy. He also participates in advisory councils for AstraZeneca and Daiichi Sankyo, Inc. His multifaceted roles reflect his commitment to advancing healthcare and medical research.